The membrane-bound aspartyl protease BACE1: Molecular and functional properties in Alzheimer's disease and beyond

Frontiers in Physiology

Volumn 3 FEB, Issue , 2012, Pages

  Dislich, Bastian ^a   Lichtenthaler, Stefan F ^a  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Amyloid beta; Aspartic protease; Beta secretase; Neurodegeneration; Regulated intramembrane proteolysis

Indexed keywords

EID: 84866291339     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00008     Document Type: Review

References (205)

1. Abad-Rodriguez, J., Ledesma, M. D., Craessaerts, K., Perga, S., Medina, M., Delacourte, A., Dingwall, C., De Strooper, B., and Dotti, C. G. (2004). Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167, 953-960.
2. Akpinar, P., Kuwajima, S., Krutzfeldt, J., and Stoffel, M. (2005). Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab. 2, 385-397.
3. Atwal, J. K., Chen, Y., Chiu, C., Mortensen, D. L., Meilandt, W. J., Liu, Y., Heise, C. E., Hoyte, K., Luk, W., Lu, Y., Peng, K., Wu, P., Rouge, L., Zhang, Y., Lazarus, R. A., Scearce-Levie, K., Wang, W., Wu, Y., Tessier-Lavigne, M., and Watts, R. J. (2011). A therapeutic antibody targeting BACE1 inhibits amyloid-beta production in vivo. Sci. Transl. Med. 3, 84ra43.
4. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer's disease. Lancet 377, 1019-1031.
5. Benjannet, S., Cromlish, J. A., Diallo, K., Chretien, M., and Seidah, N. G. (2004). The metabolism of beta-amyloid converting enzyme and beta-amyloid precursor protein processing. Biochem. Biophys. Res. Com-mun. 325, 235-242.
6. Benjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J. S., Basak, A., Lazure, C., Cromlish, J. A., Sisodia, S., Checler, F., Chretien, M., and Seidah, N. G. (2001). Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The proand transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 10879-10887.
7. Bennett, B. D., Babu-Khan, S., Loeloff, R., Louis, J. C., Curran, E., Citron, M., and Vassar, R. (2000a). Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275, 20647-20651.
8. Bennett, B. D., Denis, P., Haniu, M., Teplow, D. B., Kahn, S., Louis, J. C., Citron, M., and Vassar, R. (2000b). A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase. J. Biol. Chem. 275, 37712-37717.
9. Birchmeier, C., and Nave, K. A. (2008). Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56, 1491-1497.
10. Bodendorf, U., Fischer, F., Bodian, D., Multhaup, G., and Paganetti, P. (2001). A splice variant of beta-secretase deficient in the amyloido-genic processing of the amyloid precursor protein. J. Biol. Chem. 276, 12019-12023.
11. Brackenbury, W. J., Djamgoz, M. B., and Isom, L. L. (2008). An emerging role for voltage-gated Na+ channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers. Neuroscientist 14, 571-583.
12. Brinkmann, B. G., Agarwal, A., Sereda, M. W., Garratt, A. N., Muller, T., Wende, H., Stassart, R. M., Nawaz, S., Humml, C., Velanac, V., Radyushkin, K., Goebbels, S., Fischer, T. M., Franklin, R. J., Lai, C., Ehrenre-ich, H., Birchmeier, C., Schwab, M. H., and Nave, K. A. (2008). Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59, 581-595.
13. Brown, M. S., Ye, J., Rawson, R. B., and Goldstein, J. L. (2000). Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398.
14. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cer-retti, D. P., and Black, R. A. (1998). Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767.
15. Cai, H., Wang, Y., Mccarthy, D., Wen, H., Borchelt, D. R., Price, D. L., and Wong, P. C. (2001). BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233-234.
16. Capell, A., Steiner, H., Willem, M., Kaiser, H., Meyer, C., Walter, J., Lammich, S., Multhaup, G., and Haass, C. (2000). Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275, 30849-30854.
17. Carlow, D. A., Gossens, K., Naus, S., Veerman, K. M., Seo, W., and Zil-tener, H. J. (2009). PSGL-1 function in immunity and steady state home-ostasis. Immunol. Rev. 230, 75-96.
18. Carteron, C., Ferrer-Montiel, A., and Cabedo, H. (2006). Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J. Cell Sci. 119, 898-909.
19. Catterall, W. A. (2000). From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13-25.
20. Chang, W. P., Downs, D., Huang, X. P., Da, H., Fung, K. M., and Tang, J. (2007). Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization. FASEB J. 21, 3184-3196.
21. Chen, M., and Geng, J. G. (2006). P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch. Immunol. Ther. Exp. (Warsz.) 54, 75-84.
22. Chyung, J. H., and Selkoe, D. J. (2003). Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J. Biol. Chem. 278, 51035-51043.
23. Citron, M., Oltersdorf, T., Haass, C., Mcconlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieber-burg, I., and Selkoe, D. J. (1992). Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674.
24. Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., and De Jonghe, P. (2001). De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68, 1327-1332.
25. Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M., and Turner, A. J. (2003). Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 100, 11735-11740.
26. Costantini, C., Ko, M. H., Jonas, M. C., and Puglielli, L. (2007). A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1. Biochem. J. 407, 383-395.
27. Crameri, A., Biondi, E., Kuehnle, K., Lutjohann, D., Thelen, K. M., Perga, S., Dotti, C. G., Nitsch, R. M., Ledesma, M. D., and Mohajeri, M. H. (2006). The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J. 25, 432-443.
28. Creemers, J. W., Ines Dominguez, D., Plets, E., Serneels, L., Taylor, N. A., Multhaup, G., Craessaerts, K., Annaert, W., and De Strooper, B. (2001). Processing of beta-secretase by furin and other members of the proprotein convertase family. J. Biol. Chem. 276, 4211-4217.
29. De Pietri Tonelli, D., Mihailovich, M., Di Cesare, A., Codazzi, F., Groho-vaz, F., and Zacchetti, D. (2004). Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. Nucleic Acids Res. 32, 1808-1817.
30. Dominguez, D., Tournoy, J., Hartmann, D., Huth, T., Cryns, K., Deforce, S., Serneels, L., Camacho, I. E., Mar-jaux, E., Craessaerts, K., Roebroek, A. J., Schwake, M., D'Hooge, R., Bach, P., Kalinke, U., Moechars, D., Alzheimer, C., Reiss, K., Saftig, P., and De Strooper, B. (2005). Phenotypic and biochemical analyses of BACE1-and BACE2-deficient mice. J. Biol. Chem. 280, 30797-30806.
31. Eggert, S., Paliga, K., Soba, P., Evin, G., Masters, C. L., Weidemann, A., and Beyreuther, K. (2004). The pro-teolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. J. Biol. Chem. 279, 18146-18156.
32. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. (2003). Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113-123.
33. Ehehalt, R., Michel, B., De Pietri Tonelli, D., Zacchetti, D., Simons, K., and Keller, P. (2002). Splice variants of the beta-site APP-cleaving enzyme BACE1 in human brain and pancreas. Biochem. Biophys. Res. Com-mun. 293, 30-37.
34. Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Olters-dorf, T., Mcclure, D., and Ward, P. J. (1990). Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124.
35. Esterhazy, D., Stutzer, I., Wang, H., Rechsteiner, M. P., Beauchamp, J., Dobeli, H., Hilpert, H., Matile, H., Prummer, M., Schmidt, A., Lieske, N., Boehm, B., Marselli, L., Bosco, D., Kerr-Conte, J., Aebersold, R., Spinas, G. A., Moch, H., Migliorini, C., and Stoffel, M. (2011). Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass. Cell Metab. 14, 365-377.
36. Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St Laurent, G. III, Kenny, P. J., and Wahlestedt, C. (2008). Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 14, 723-730.
37. Falls, D. L. (2003). Neuregulins: func-tions,forms, and signaling strategies. Exp. Cell Res. 284, 14-30.
38. Farah, M. H., Pan, B. H., Hoffman, P. N., Ferraris, D., Tsukamoto, T., Nguyen, T., Wong, P. C., Price, D. L., Slusher, B. S., and Griffin, J. W. (2011). Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J. Neurosci. 31, 5744-5754.
39. Farzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., and Choe, H. (2000). BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97, 9712-9717.
40. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
41. Finan, G. M., Okada, H., and Kim, T. W. (2011). BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. J. Biol. Chem. 286, 12602-12616.
42. Fluhrer, R., Capell, A., Westmeyer, G., Willem, M., Hartung, B., Con-dron, M. M., Teplow, D. B., Haass, C., and Walter, J. (2002). A non-amyloidogenic function of BACE-2 in the secretory pathway. J. Neu-rochem. 81, 1011-1020.
43. Fukumoto, H., Cheung, B. S., Hyman, B. T., and Irizarry, M. C. (2002). Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 1381-1389.
44. Fukumoto, H., Takahashi, H., Tarui, N., Matsui, J., Tomita, T., Hirode, M., Sagayama, M., Maeda, R., Kawamoto, M., Hirai, K., Ter-auchi, J., Sakura, Y., Kakihana, M., Kato, K., Iwatsubo, T., and Miyamoto, M. (2010). A noncom-petitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease. J. Neurosci. 30, 11157-11166.
45. Ghosh, A. K., Bilcer, G., Harwood, C., Kawahama, R., Shin, D., Hussain, K. A., Hong, L., Loy, J. A., Nguyen, C., Koelsch, G., Ermolieff, J., and Tang, J. (2001). Structure-based design: potent inhibitors of human brain memapsin 2 (beta-secretase). J. Med. Chem. 44, 2865-2868.
46. Gruninger-Leitch, F., Schlatter, D., Kung, E., Nelbock, P., and Dobeli, H. (2002). Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases. J. Biol. Chem. 277, 4687-4693.
47. Haass, C., Hung, A. Y., Schlossmacher, M. G., Oltersdorf, T., Teplow, D. B., and Selkoe, D. J. (1993). Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann. N. Y. Acad. Sci. 695, 109-116.
48. Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lan-nfelt, L., and Selkoe, D. J. (1995). The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat. Med. 1, 1291-1296.
49. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neu-rodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112.
50. Hahn, C. G., Wang, H. Y., Cho, D. S., Tal-bot, K., Gur, R. E., Berrettini, W. H., Bakshi, K., Kamins, J., Borgmann-Winter, K. E., Siegel, S. J., Gallop, R. J., and Arnold, S. E. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypo-function in schizophrenia. Nat. Med. 12, 824-828.
51. Haniu, M., Denis, P., Young, Y., Mendiaz, E. A., Fuller, J., Hui, J. O., Bennett, B. D., Kahn, S., Ross, S., Burgess, T., Katta, V., Rogers, G., Vassar, R., and Citron, M. (2000). Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. J. Biol. Chem. 275, 21099-21106.
52. Hao, M., Mukherjee, S., Sun, Y., and Maxfield, F.R. (2004). Effectsof cholesterol depletion and increased lipid unsaturation on the properties of endocytic membranes. J. Biol. Chem. 279, 14171-14178.
53. Haque, A., Banik, N. L., and Ray, S. K. (2008). New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol. Dis-ord. Drug Targets 7, 270-277.
54. Harada, H., Tamaoka, A., Ishii, K., Shoji, S., Kametaka, S., Kametani, F., Saito, Y., and Murayama, S. (2006). Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neurosci. Res. 54, 24-29.
55. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
56. Harrison, S. M., Harper, A. J., Hawkins, J., Duddy, G., Grau, E., Pugh, P. L., Winter, P. H., Shilliam, C. S., Hughes, Z. A., Dawson, L. A., Gonzalez, M. I., Upton, N., Pangalos, M. N., and Dingwall, C. (2003). BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemi-cal deficits and behavioral changes. Mol. Cell. Neurosci. 24, 646-655.
57. Hattori, C., Asai, M., Onishi, H., Sasagawa, N., Hashimoto, Y., Saido, T. C., Maruyama, K., Mizutani, S., and Ishiura, S. (2006). BACE1 interacts with lipid raft proteins. J. Neu-rosci. Res. 84, 912-917.
58. He, X., Chang, W. P., Koelsch, G., and Tang, J. (2002). Memapsin 2 (beta-secretase) cytosolic domain binds to the VHS domains of GGA1 and GGA2: implications on the endo-cytosis mechanism of memapsin 2. FEBS Lett. 524, 183-187.
59. He, X., Li, F., Chang, W. P., and Tang, J. (2005). GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J. Biol. Chem. 280, 11696-11703.
60. He, X., Zhu, G., Koelsch, G., Rodgers, K. K., Zhang, X. C., and Tang, J. (2003). Biochemical and structural characterizationof the interaction of memapsin 2 (beta-secretase) cytoso-lic domain with the VHS domain of GGA proteins. Biochemistry 42, 12174-12180.
61. Heber, S., Herms, J. Gajic, V., Hain-fellner, J., Aguzzi, A., Rülicke T., von Kretschmar, H., von Koch, C., Sisodia, S., Tremml, P., Lipp, H. P., Wolfer, D. P., and Müller, U. (2000). Mice with combined gene knockouts reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963.
62. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mande-makers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., and De Strooper, B. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420.
63. Hemming, M. L., Elias, J. E., Gygi, S. P., and Selkoe, D. J. (2009). Identification of beta-secretase (BACE1) substrates using quantitative pro-teomics. PLoS ONE 4, e8477. doi:10.1371/journal.pone.0008477
64. Hitt, B. D., Jaramillo, T. C., Chetkovich, D. M., andVassar, R. (2010). BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Mol. Neurodegener. 5, 31.
65. Hoffmeister, A., Dietz, G., Zeitschel, U., Mössner, J., Rossner, S., and Stahl, T. (2009). BACE1 is a newly discovered protein secreted by the pancreas which cleaves enteropeptidase in vitro. JOP 10, 481-484.
66. Hogl, S., Kuhn, P. H., Colombo, A., and Lichtenthaler, S. F. (2011). Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and gamma-secretase. PLoS ONE 6, e21337. doi:10.1371/jour-nal.pone.0021337
67. Holsinger, R. M., Mclean, C. A., Beyreuther, K., Masters, C. L., and Evin, G. (2002). Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann. Neurol. 51, 783-786.
68. Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A. K., Zhang, X. C., and Tang, J. (2000). Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290, 150-153.
69. Hook, G., Hook, V., and Kindy, M. (2011). The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity. J. Alzheimers Dis. 26, 387-408.
70. Hook, V. Y., Kindy, M., and Hook, G. (2008). Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J. Biol. Chem. 283, 7745-7753.
71. Hu, X., He, W., Diaconu, C., Tang, X., Kidd, G. J., Macklin, W. B., Trapp, B. D., and Yan, R. (2008). Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J. 22, 2970-2980.
72. Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., and Yan, R. (2006). Bace1 modulates myeli-nation in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525.
73. Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., and Yan, R. (2010). BACE1 deficiency causes altered neuronal activity and neurodegeneration. J. Neurosci. 30, 8819-8829.
74. Huse, J. T., Pijak, D. S., Leslie, G. J., Lee, V. M., and Doms, R.W. (2000). Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. J. Biol. Chem. 275, 33729-33737.
75. Hussain, I., Hawkins, J., Shikotra, A., Riddell, D. R., Faller, A., and Ding-wall, C. (2003). Characterization of the ectodomain shedding of the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). J. Biol. Chem. 278, 36264-36268.
76. Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., Smith, T. S., Simmons, D. L., Walsh, F.S., Dingwall, C., and Christie, G. (1999). Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419-427.
77. Hussain, I., Powell, D. J., Howlett, D. R., Chapman, G. A., Gilmour, L., Murdock, P. R., Tew, D. G., Meek, T. D., Chapman, C., Schneider, K., Ratcliffe, S. J., Tattersall, D., Testa, T. T., Southan, C., Ryan, D. M., Simmons, D. L., Walsh, F. S., Ding-wall, C., and Christie, G. (2000). ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol. Cell. Neurosci. 16, 609-619.
78. Irizarry, M. C., Locascio, J. J., and Hyman, B. T. (2001). beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging. Am. J. Pathol. 158, 173-177.
79. Isom, L. L. (2001). Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7, 42-54.
80. Isom, L. L. (2002). The role of sodium channels in cell adhesion. Front. Biosci. 7, 12-23.
81. Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., Snellinx, A., Craes-saerts, K., Thathiah, A., Tesseur, I., Bartsch, U., Weskamp, G., Blobel, C.P., Glatzel, M., De Strooper, B., and Saftig, P. (2010). The disinte-grin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 30, 4833-4844.
82. Kaether, C., and Haass, C. (2004). A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J. Cell Biol. 167, 809-812.
83. Kang, E. L., Cameron, A. N., Piazza, F., Walker, K. R., and Tesco, G. (2010). Ubiquitin regulates GGA3-mediated degradation of BACE1. J. Biol. Chem. 285, 24108-24119.
84. Kao, W.T., Wang, Y., Kleinman, J.E., Lip-ska, B. K., Hyde, T. M., Weinberger, D.R., and Law, A. J. (2010). Com mon genetic variation in Neuregulin 3 (NRG3) influences risk for schizo phrenia and impacts NRG3 expres sion in human brain. Proc. Natl. Acad. Sci. 107, 15619-15624.
85. Kaplan, H. A., Woloski, B. M., Hellman, M., and Jamieson, J. C. (1983). Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4Glc-NAc alpha 2 leads to 6 sialyltrans-ferase from liver. J. Biol. Chem. 258, 11505-11509.
86. Kawarabayashi, T., Shoji, M., Younkin, L. H., Wen-Lang, L., Dickson, D. W., Murakami, T., Matsubara, E., Abe, K., Ashe, K. H., and Younkin, S. G. (2004). Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 24, 3801-3809.
87. Kim, D. Y., Carey, B. W., Wang, H., Ingano, L. A., Binshtok, A. M., Wertz, M. H., Pettingell, W. H., He, P., Lee, V. M., Woolf, C. J., and Kovacs, D. M. (2007). BACE1 regulates voltage-gated sodium channels and neu-ronal activity. Nat. Cell Biol. 9, 755-764.
88. Kim, D., and Tsai, L. H. (2009). Bridging physiology and pathology in AD. Cell 137, 997-1000.
89. Kim, D. Y., Gersbacher, M. T., Inquim-bert, P., and Kovacs, D. M. (2011). Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J. Biol. Chem. 286, 8106-8116.
90. Kitagawa, H., and Paulson, J. C. (1994). Differential expression of five sialyl-transferase genes in human tissues. J. Biol. Chem. 269, 17872-17878.
91. Kitazume, S., Nakagawa, K., Oka, R., Tachida, Y., Ogawa, K., Luo, Y., Citron, M., Shitara, H., Taya, C., Yonekawa, H., Paulson, J. C., Miyoshi, E., Taniguchi, N., and Hashimoto, Y. (2005). In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase. J. Biol. Chem. 280, 8589-8595.
92. Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., and Hashimoto, Y. (2001). Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltrans-ferase. Proc. Natl. Acad. Sci. U.S.A. 98, 13554-13559.
93. Ko, M. H., and Puglielli, L. (2009). Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels. J. Biol. Chem. 284, 2482-2492.
94. Koike, H., Tomioka, S., Sorimachi, H., Saido, T. C., Maruyama, K., Okuyama, A., Fujisawa-Sehara, A., Ohno, S., Suzuki, K., and Ishiura, S. (1999). Membrane-anchored met-alloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343(Pt 2), 371-375.
95. Koo, E. H., and Squazzo, S. L. (1994). Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
96. Kovacs, D. M., Gersbacher, M. T., and Kim, D. Y. (2010). Alzheimer's secretases regulate voltage-gated sodium channels. Neurosci. Lett. 486, 68-72.
97. Kuhn, P. H., Marjaux, E., Imhof, A., De Strooper, B., Haass, C, and Lich-tenthaler, S. F. (2007). Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-beta-and gamma-secretase. J. Biol. Chem. 282, 11982-11995.
98. Kuhn, P. H., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ell-wart, J. W., Kremmer, E., Rossner, S., and Lichtenthaler, S. F. (2010). ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032.
99. Kvajo, M., Mckellar, H., Arguello, P. A., Drew, L. J., Moore, H., Macdermott, A. B., Karayiorgou, M., and Gogos, J. A. (2008). A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. U.S.A. 105, 7076-7081.
100. La Marca, R., Cerri, F., Horiuchi, K., Bachi, A., Feltri, M. L., Wrabetz, L., Blobel, C. P., Quattrini, A., Salzer, J. L., and Taveggia, C. (2011). TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865.
101. Laird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., Wen, H., Chiang, H. C., Xu, G., Koli-atsos, V. E., Borchelt, D. R., Price, D. L., Lee, H. K., and Wong, P. C. (2005). BACE1, amajor determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25,11693-11709.
102. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C, and Fahrenholz, F. (1999). Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metallopro-tease. Proc. Natl Acad. Sci. U.S.A. 96, 3922-3927.
103. Lammich, S., Schobel, S., Zimmer, A. K., Lichtenthaler, S. F., and Haass, C. (2004). Expression of the Alzheimer protease BACE1 is suppressed via its 5;-untranslated region. EMBO Rep. 5, 620-625.
104. Lazarov, O., Lee, M., Peterson, D. A., and Sisodia, S. S. (2002). Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci. 22, 9785-9793.
105. Li, H., Wang, B., Wang, Z., Guo, Q., Tabuchi, K., Hammer, R. E., Sud-hof, T. C, and Zheng, H. (2010). Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc. Natl. Acad. Sci. U.S.A. 107, 17362-17367.
106. Li, Q., and Südhof, T. C. (2004). Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE1. J. Biol. Chem. 279, 10542-10550.
107. Li, R., Lindholm, K., Yang, L. B., Yue, X., Citron, M., Yan, R., Beach, T., Sue, L., Sabbagh, M., Cai, H., Wong, P., Price, D., and Shen, Y. (2004). Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl. Acad. Sci. U.S.A. 101, 3632-3637.
108. Lichtenthaler, S. F., Dominguez, D. I., Westmeyer, G. G., Reiss, K., Haass, C., Saftig, P., De Strooper, B., and Seed, B. (2003). The cell adhesion protein P-selectin glycopro-tein ligand-1 is a substrate for the aspartyl protease BACE1. J. Biol. Chem. 278, 48713-48719.
109. Lichtenthaler, S. F., Haass, C., and Steiner, H. (2011). Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing. J. Neurochem. 117, 779-796.
110. Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., and Strickland, D. K. (2008). LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887-918.
111. Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., and Tang, J. (2000). Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97, 1456-1460.
112. Luo, X., Prior, M., He, W., Hu, X., Tang, X., Shen, W., Yadav, S., Kiryu-Seo, S., Miller, R., Trapp, B. D., and Yan, R. (2011). Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J. Biol. Chem. 286, 23967-23974.
113. Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., Martin, L., Louis, J. C., Yan, Q., Richards, W. G., Citron, M., and Vassar, R. (2001). Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neu-rosci. 4, 231-232.
114. Matsui, T., Ingelsson, M., Fukumoto, H., Ramasamy, K., Kowa, H., Frosch, M. P., Irizarry, M. C., and Hyman, B.T. (2007). Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Res. 1161, 116-123.
115. May, P. C, Dean, R. A., Lowe, S. L., Martenyi, F., Sheehan, S. M., Boggs, L. N., Monk, S. A., Mathes, B. M., Mergott, D. J., Watson, B. M., Stout, S. L., Timm, D. E., Smith Labell, E., Gonzales, C. R., Nakano, M., Jhee, S. S., Yen, M., Ereshefsky, L., Lindstrom, T. D., Calligaro, D. O., Cocke, P. J., Greg Hall, D., Friedrich, S., Citron, M., and Audia, J. E. (2011). Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor. J. Neurosci. 31, 16507-16516.
116. Meakin, P. J., Harper, A. J., Hamilton, D. L., Gallagher, J., Mcneilly, A. D., Burgess, L. A., Vaanholt, L. M., Ban-non, K. A., Latcham, J., Hussain, I., Speakman, J. R., Howlett, D. R., and Ashford, M. L. (2012). Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem. J. 441, 285-296.
117. Mei, L., and Xiong, W. C. (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9,437-452.
118. Mihailovich, M., Thermann, R., Gro-hovaz, F., Hentze, M. W., and Zac-chetti, D. (2007). Complex transla-tional regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5! untranslated region. Nucleic Acids Res. 35, 2975-2985.
119. Mitterreiter, S., Page, R. M., Kamp, F., Hopson, J., Winkler, E., Ha, H. R., Hamid, R., Herms, J., Mayer, T. U., Nelson, D. J., Steiner, H., Stahl, T., Zeitschel, U., Rossner, S., Haass, C, and Lichtenthaler, S. F. (2010). Bepridil and amiodarone simultane ously target the Alzheimer's disease beta-and gamma-secretase via dis tinct mechanisms. J. Neurosci. 30, 8974-8983.
120. Molinari, M., Galli, C, Piccaluga, V., Pieren, M., and Paganetti, P. (2002). Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J. Cell Biol. 158, 247-257.
121. Mowrer, K. R., and Wolfe, M. S. (2008). Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production. J. Biol. Chem. 283, 18694-18701.
122. Mullan, M., Crawford, F., Axelman, K., Houlden, H., LIlius, L., Win-blad, B., and Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of b-amyloid. Nat. Genet. 1, 345-347.
123. Muller, U., Cristina, N., Li, Z. W., Wolfer, D. P., Lipp, H. P., Rulicke, T., Brand-ner, S., Aguzzi, A., and Weissmann, C. (1994). Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell 79, 755-765.
124. Mulley, J. C., Scheffer, I. E., Petrou, S., Dibbens, L. M., Berkovic, S. F., and Harkin, L. A. (2005). SCN1A mutations and epilepsy. Hum. Mutat. 25, 535-542.
125. Naus, S., Reipschlager, S., Wildeboer, D., Lichtenthaler, S. F., Mitterreiter, S., Guan, Z., Moss, M. L., and Bartsch, J. W. (2006). Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol. Chem. 387, 337-346.
126. Neumann, S., Schobel, S., Jager, S., Trautwein, A., Haass, C., Pietrzik, C. U., and Lichtenthaler, S. F. (2006). Amyloid precursor-like protein 1 influences endocytosis and prote-olytic processing of the amyloid precursor protein. J. Biol. Chem. 281, 7583-7594.
127. Nikolaev, A., Mclaughlin, T., O'Leary, D. D., and Tessier-Lavigne, M. (2009). APP binds DR6totriggeraxonprun-ing and neuron death via distinct caspases. Nature 457, 981-989.
128. O'Brien, R. J., and Wong, P. C. (2011). Amyloid precursor protein processing and Alzheimer's disease. Annu. Rev. Neurosci. 34, 185-204.
129. O'Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., Eimer, W. A., Hitt, B., Bem-binster, L. A., Lammich, S., Lich-tenthaler, S. F., Hebert, S. S., De Strooper, B., Haass, C., Bennett, D. A., and Vassar, R. (2008). Phospho-rylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogene-sis. Neuron 60, 988-1009.
130. Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., and Disterhoft, J. F. (2004). BACE1 deficiency rescues memory deficits and choliner-gic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27-33.
131. Ostermann, N., Eder, J., Eidhoff, U., Zink, F., Hassiepen, U., Worpenberg, S., Maibaum, J., Simic, O., Hom-mel, U., and Gerhartz, B. (2006). Crystal structure of human BACE2 in complex with a hydroxyethy-lamine transition-state inhibitor. J. Mol. Biol. 355, 249-261.
132. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., Flamez, P., Dequenne, A., Godaux, E., Van Leuven, F., and Fahrenholz, F. (2004). A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocam-pal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456-1464.
133. Preece, P., Virley, D. J., Costandi, M., Coombes, R., Moss, S. J., Mudge, A. W., Jazin, E., and Cairns, N. J. (2003). Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. Brain Res. Mol. Brain Res. 116, 155-158.
134. Qing, H., Zhou, W., Christensen, M. A., Sun, X., Tong, Y., and Song, W. (2004). Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J. 18, 1571-1573.
135. Rajendran, L., Schneider, A., Schlechtin-gen, G., Weidlich, S., Ries, J., Braxmeier, T., Schwille, P., Schulz, J. B., Schroeder, C., Simons, M., Jennings, G., Knolker, H. J., and Simons, K. (2008). Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science 320, 520-523.
136. Refolo, L. M., Pappolla, M. A., Lafran-cois, J., Malester, B., Schmidt, S. D., Thomas-Bryant, T., Tint, G. S., Wang, R., Mercken, M., Petanceska, S. S., and Duff, K. E. (2001). A cholesterol-lowering drug reduces beta-amyloid pathology in a trans-genic mouse model of Alzheimer's disease. Neurobiol. Dis. 8, 890-899.
137. Riddell, D. R., Christie, G., Hussain, I., and Dingwall, C. (2001). Com-partmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11, 1288-1293.
138. Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filip-pov, M. A., Herms, J., Buchholz, C., Eckman, C. B., Korte, M., Wolfer, D. P., and Muller, U. C. (2007). The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiologi-cal abnormalities of APP-deficient mice. J. Neurosci. 27, 7817-7826.
139. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S., Freedman, S. B., Frigon, N. L., Games, D., Hu, K., Johnson-Wood, K., Kappenman, K. E., Kawabe, T. T., Kola, I., Kuehn, R., Lee, M., Liu, W., Motter, R., Nichols, N. F., Power, M., Robertson, D. W., Schenk, D., Schoor, M., Shopp, G. M., Shuck, M. E., Sinha, S., Svensson, K. A., Tatsuno, G., Tintrup, H., Wijs-man, J., Wright, S., and Mcconlogue, L. (2001). BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317-1324.
140. Rodal, S. K., Skretting, G., Garred, O., Vilhardt, F., Van Deurs, B., and Sandvig, K. (1999). Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10, 961-974.
141. Rogers, G. W. Jr., Edelman, G. M., and Mauro, V. P. (2004). Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation. Proc. Natl. Acad. Sci. U.S.A. 101, 2794-2799.
142. Rossner, S., Sastre, M., Bourne, K., and Lichtenthaler, S. F. (2006). Tran-scriptional and translational regulation of BACE1 expression - implications for Alzheimer's disease. Prog. Neurobiol. 79, 95-111.
143. Sagane, K., Hayakawa, K., Kai, J., Hirohashi, T., Takahashi, E., Miyamoto, N., Ino, M., Oki, T., Yamazaki, K., and Nagasu, T. (2005). Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci. 6, 33. doi:10.1186/1471-2202-6-33
144. Sala Frigerio, C., Fadeeva, J. V., Minogue, A. M., Citron, M., Van Leu-ven, F., Staufenbiel, M., Paganetti, P., Selkoe, D. J., and Walsh, D. M. (2010). beta-Secretase cleavage is not required for generation of the intracellular C-terminal domain of the amyloid precursor family of proteins. FEBS J. 277, 1503-1518.
145. Sankaranarayanan, S., Holahan, M. A., Colussi, D., Crouthamel, M. C., Devanarayan, V., Ellis, J., Espeseth, A., Gates, A. T., Graham, S. L., Gre-gro, A. R., Hazuda, D., Hochman, J. H., Holloway, K., Jin, L., Kahana, J., Lai, M. T., Lineberger, J., Mcgaughey, G., Moore, K. P., Nantermet, P., Pietrak, B., Price, E. A., Rajapakse, H., Stauffer, S., Steinbeiser, M. A., Seabrook, G., Selnick, H. G., Shi, X. P., Stanton, M. G., Swestock, J., Tugusheva, K., Tyler, K. X., Vacca, J. P., Wong, J., Wu, G., Xu, M., Cook, J. J., and Simon, A. J. (2009). First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in non-human primates. J. Pharmacol. Exp. Ther. 328, 131-140.
146. Sankaranarayanan, S., Price, E. A., Wu, G., Crouthamel, M. C., Shi, X. P., Tugusheva, K., Tyler, K. X., Kahana, J., Ellis, J., Jin, L., Steele, T., Stachel, S., Coburn, C., and Simon, A. J. (2008). In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. J. Pharmacol. Exp. Ther. 324, 957-969.
147. Sannerud, R., Declerck, I., Peric, A., Rae-maekers, T., Menendez, G., Zhou, L., Veerle, B., Coen, K., Munck, S., De Strooper, B., Schiavo, G., and Annaert, W. (2011). ADP ribosyla-tion factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1. Proc. Natl. Acad. Sci. U.S.A. 108, E559-E568.
148. Santosa, C., Rasche, S., Barakat, A., Bellingham, S. A., Ho, M., Tan, J., Hill, A. F., Masters, C. L., Mclean, C., and Evin, G. (2011). Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Neurobiol. Dis. 43, 176-183.
149. Sarajarvi, T., Haapasalo, A., Viswanathan, J., Makinen, P., Laiti-nen, M., Soininen, H., and Hiltunen, M. (2009). Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis. J. Biol. Chem. 284, 34433-34443.
150. Sarnesto, A., Kohlin, T., Hindsgaul, O., Thurin, J., and Blaszczyk-Thurin, M. (1992). Purification of the secretor-type beta-galactoside alpha 1-2-fucosyltransferase from human serum. J. Biol. Chem. 267, 2737-2744.
151. Savonenko, A. V., Melnikova, T., Laird, F. M., Stewart, K. A., Price, D. L., and Wong, P. C. (2008). Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc. Natl. Acad. Sci. U.S.A. 105, 5585-5590.
152. Schmechel, A., Strauss, M., Schlicksupp, A., Pipkorn, R., Haass, C., Bayer, T. A., and Multhaup, G.(2004). Human BACE forms dimers and colocal-izes with APP. J. Biol. Chem. 279, 39710-39717.
153. Schobel, S., Neumann, S., Hertweck, M., Dislich, B., Kuhn, P. H., Kremmer, E., Seed, B., Baumeister, R., Haass, C., and Lichtenthaler, S. F. (2008). A novel sorting nexin modulates endo-cytic trafficking and alpha-secretase cleavage of the amyloid precursor protein. J. Biol. Chem. 283, 14257-14268.
154. Schobel, S., Neumann, S., Seed, B., and Lichtenthaler, S. F. (2006). Expression cloning screen for modifiers of amyloid precursor protein shedding. Int. J. Dev. Neurosci. 24, 141-148.
155. Schroder, M., and Kaufman, R. J. (2006). Divergent roles of IRE1alpha and PERK in the unfolded protein response. Curr. Mol. Med. 6, 5-36.
156. Seshadri, S., Kamiya, A., Yokota, Y., Prikulis, I., Kano, S., Hayashi-Takagi, A., Stanco, A., Eom, T. Y., Rao, S., Ishizuka, K., Wong, P., Korth, C., Anton, E. S., and Sawa, A. (2010). Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl. Acad. Sci. U.S.A. 107, 5622-5627.
157. Sheng, J. G., Price, D. L., and Koliatsos, V. E.(2003). The beta-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve termi nals in the brain. Exp. Neurol. 184, 1053-1057.
158. Shi, X. P., Chen, E., Yin, K. C., Na, S., Garsky, V. M., Lai, M. T., Li, Y. M., Platchek, M., Register, R. B., Sar-dana, M. K., Tang, M. J., Thiebeau, J., Wood, T., Shafer, J. A., and Gardell, S. J. (2001). The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. J. Biol. Chem. 276, 10366-10373.
159. Shimizu, H., Tosaki, A., Kaneko, K., Hisano, T., Sakurai, T., and Nukina, N. (2008). Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol. Cell. Biol. 28, 3663-3671.
160. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998). Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95, 6460-6464.
161. Singer, O., Marr, R. A., Rockenstein, E., Crews, L., Coufal, N. G., Gage, F H., Verma, I. M., and Masliah, E. (2005). Targeting BACE1 with siRNAs ameliorates Alzheimer dis ease neuropathology in a transgenic model. Nat. Neurosci. 8, 1343-1349.
162. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jew-ett, N., Keim, P., Knops, J., Lieber-burg, I., Power, M., Tan, H., Tat-suno, G., Tung, J., Schenk, D., Seu-bert, P., Suomensaari, S. M., Wang, S., Walker, D., Zhao, J., Mcconlogue, L., and John, V. (1999). Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
163. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdot-tir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdot-tir, E., Bjornsson, A., Ingvarsson, B., Ingason, A., Sigfusson, S., Hardar-dottir, H., Harvey, R. P., Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H., and Stefansson, K. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892.
164. Steiner, H., Fluhrer, R., and Haass, C. (2008). Intramembrane proteolysis by gamma-secretase. J. Biol. Chem. 283, 29627-29631.
165. Stockley, J. H., and O'Neill, C. (2008). Understanding BACE1: essential protease for amyloid-beta production in Alzheimer's disease. Cell. Mol. Life Sci. 65, 3265-3289.
166. Sugimoto, I., Futakawa, S., Oka, R., Ogawa, K., Marth, J. D., Miyoshi, E., Taniguchi, N., Hashimoto, Y., and Kitazume, S. (2007). Beta-galactoside alpha2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for alpha2,6-sialylation. J. Biol. Chem. 282, 34896-34903.
167. Takasugi, N., Sasaki, T., Suzuki, K., Osawa, S., Isshiki, H., Hori, Y., Shimada, N., Higo, T., Yokoshima, S., Fukuyama, T., Lee, V. M., Tro-janowski, J. Q., Tomita, T., and Iwatsubo, T. (2011). BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J. Neu-rosci. 31, 6850-6857.
168. Tamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., Gilib-erto, L., Muraca, G., Danni, O., Zhu, X., Smith, M. A., Perry, G., Jo, D. G., Mattson, M. P., and Tabaton, M. (2008). Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 104, 683-695.
169. Tamagno, E., Guglielmotto, M., Gilib-erto, L., Vitali, A., Borghi, R., Autelli, R., Danni, O., and Tabaton, M. (2009). JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. Neurobiol. Aging 30, 1563-1573.
170. Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Gugliel-motto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., Perry, G., and Tabaton, M. (2005). Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628-636.
171. Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S. H., Zhong, Z., Shen, Y., Simp-kins, J. W., and Tanzi, R. E. (2007). Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54, 721-737.
172. Tun, H., Marlow, L., Pinnix, I., Kin-sey, R., and Sambamurti, K. (2002). Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. J. Mol. Neurosci. 19, 31-35.
173. Turner, R. T. III, Hong, L., Koelsch, G., Ghosh, A. K., and Tang, J. (2005). Structural locations and functional roles of new subsites S5, S6, and S7 in memapsin 2 (beta-secretase). Biochemistry 44, 105-112.
174. Turner, R. T. III, Loy, J. A., Nguyen, C., Devasamudram, T., Ghosh, A. K., Koelsch, G., and Tang, J. (2002). Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity. Biochemistry 41, 8742-8746.
175. Vargas, M. E., Watanabe, J., Singh, S. J., Robinson, W. H., and Barres, B. A. (2010). Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc. Natl. Acad. Sci. U.S.A. 107, 11993-11998.
176. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Ama-rante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
177. Velliquette, R. A., O'Connor, T., and Vassar, R. (2005). Energy inhibition elevates beta-secretase levels and activity and is potentially amy-loidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci. 25, 10874-10883.
178. Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vas-sar, R., Wong, P. C., Fukata, M., Kounnas, M. Z., and Thinakaran, G. (2009). Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J. Biol. Chem. 284, 3793-3803.
179. von Arnim, C.A., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ran-ganathan, S., Battey, F. D., Liu, C. X., Bacskai, B. J., Sever, S., Irizarry, M. C., Strickland, D. K., and Hyman, B. T. (2005). The low density lipopro-tein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J. Biol. Chem. 280, 17777-17785.
180. von Arnim, C. A., Spoelgen, R., Peltan, I. D., Deng, M., Courchesne, S., Koker, M., Matsui, T., Kowa, H., Lichtenthaler, S. F., Irizarry, M. C., and Hyman, B. T. (2006). GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing. J. Neurosci. 26, 9913-9922.
181. von Arnim, C. A., Tangredi, M. M., Peltan, I. D., Lee, B. M., Irizarry, M. C., Kinoshita, A., and Hyman, B. T. (2004). Demonstration of BACE (beta-secretase) phosphoryla-tion and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy. J. Cell. Sci. 117, 5437-5445.
182. von Koch, C. S., Zheng, H., Chen, H., Trumbauer, M., Thinakaran, G., Van Der Ploeg, L. H., Price, D. L., and Sisodia, S. S. (1997). Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661-669.
183. Wagner, T., and Pietrzik, C. U. (2011). The role of lipoprotein receptors on the physiological function of APP. Exp. Brain Res. (in press).
184. Wahle, T., Prager, K., Raffler, N., Haass, C., Famulok, M., and Walter, J. (2005). GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network. Mol. Cell. Neurosci. 29, 453-461.
185. Walter, J., Fluhrer, R., Hartung, B., Willem, M., Kaether, C., Capell, A., Lammich, S., Multhaup, G., and Haass, C. (2001). Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 276, 14634-14641.
186. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., and Nelson, P. T. (2008). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223.
187. Wang, Y., Thiele, C., and Huttner, W. B. (2000). Cholesterol is required for the formation of regulated and constitutive secretory vesicles from the trans-Golgi network. Traffic 1, 952-962.
188. Weinstein, J., Lee, E. U., Mcentee, K., Lai, P. H., and Paulson, J. C. (1987). Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor. J. Biol. Chem. 262, 17735-17743.
189. Westmeyer, G. G., Willem, M., Lichten-thaler, S. F., Lurman, G., Multhaup, G., Assfalg-Machleidt, I., Reiss, K., Saftig, P., and Haass, C. (2004). Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. J. Biol. Chem. 279, 53205-53212.
190. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., Destrooper, B., Saftig, P., Birchmeier, C., and Haass, C. (2006). Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664-666.
191. Willem, M., Lammich, S., and Haass, C.(2009). Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin. Cell Dev. Biol. 20, 175-182.
192. Williams, N. M., Preece, A., Spur-lock, G., Norton, N., Williams, H. J., Zammit, S., O'Donovan, M. C., and Owen, M. J. (2003). Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol. Psychiatry 8, 485-487.
193. Wong, H. K., Sakurai, T., Oyama, F., Kaneko, K., Wada, K., Miyazaki, H., Kurosawa, M., De Strooper, B., Saftig, P., and Nukina, N. (2005). beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J. Biol. Chem. 280, 23009-23017.
194. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L., and Gurney, M. E. (1999). Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
195. Yan, R., Han, P., Miao, H., Greengard, P., and Xu, H. (2001). The transmem-brane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. J. Biol. Chem. 276, 36788-36796.
196. Yanagida, K., Okochi, M., Tagami, S., Nakayama, T., Kodama, T. S., Nishit-omi, K., Jiang, J., Mori, K., Tatsumi, S., Arai, T., Ikeuchi, T., Kasuga, K., Tokuda, T., Kondo, M., Ikeda, M., Deguchi, K., Kazui, H., Tanaka, T., Morihara, T., Hashimoto, R., Kudo, T., Steiner, H., Haass, C., Tsuchiya, K., Akiyama, H., Kuwano, R., and Takeda, M. (2009). The 28-amino acid form of an APLP1-derived Abeta-like peptide is a surrogate marker for Abeta42 production in the central nervous system. EMBO Mol. Med. 1, 223-235.
197. Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. L., Beach, T., Sue, L., Wong, P., Price, D., Li, R., and Shen, Y. (2003). Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 3-4.
198. Yasojima, K., Mcgeer, E. G., and Mcgeer, P. L. (2001). Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919, 115-121.
199. Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., Mcknight, G. S., Scheuer, T., and Catterall, W. A. (2006). Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9, 1142-1149.
200. Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J. M., Prabhu, S., Watts, R. J., and Dennis, M.S. (2011). Boosting brain uptake of a therapeutic antibody by reducing its affinity for a tran-scytosis target. Sci. Transl. Med. 3, 84ra44.
201. Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., and Godowski, P. J. (1997). Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. 94, 9562-9567.
202. Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F. F., Xu, H., and Zhang, Y. W. (2007). Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 282, 10873-10880.
203. Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., Binder, L., and Vassar, R. (2007). Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci. 27, 3639-3649.
204. Zhou, L., Chavez-Gutierrez, L., Bock-stael, K., Sannerud, R., Annaert, W., May, P. C., Karran, E., and De Strooper, B. (2011). Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1. J. Biol. Chem. 286, 8677-8687.
205. Zhou, W., and Song, W. (2006). Leaky scanning and reinitiation regulate BACE1 gene expression. Mol. Cell. Biol. 26, 3353-3364.